Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice
NCT ID: NCT01552174
Last Updated: 2015-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
185 participants
OBSERVATIONAL
2012-03-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
NCT01091311
Meibomian Gland Dysfunction Management
NCT03652337
Efficacy and Tolerability of Blephademodex Wipes
NCT04780165
Changes of Tear-film Lipid Layer Thickness and Ocular Aberration After Treatment of Meibomian Gland Dysfunction
NCT02618304
Effect of HMG-CoA Reductase Inhibitors on the Meibomian Gland Morphology in Patients With Meibomitis
NCT04085016
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Outpatients attending general ophthalmologic consultation
* Outpatients of either sex, aged at least 18 years, seen in general ophthalmological consultation
* Patients informed of the objectives of the survey and agreeing to participate.
* Patient attending to the ophthalmological consultation for any reasons: regular check-up of chronic disease, acute symptoms, or for surgery preparation or follow up.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients informed of the objectives of the survey and agreeing to participate.
* Patient attending to the ophthalmological consultation for any reasons: regular check-up of chronic disease, acute symptoms, or for surgery preparation or follow up.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iris Pharma
INDUSTRY
Axial Biotech, Inc
INDUSTRY
Laboratoires Thea
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
José Manuel Benitez del Castillo, Professor
Role: PRINCIPAL_INVESTIGATOR
USIO, Departamento de Oftalmología, Hospital Clínico San Carlos, 28040 Madrid, Spain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Consultation office
Heidelberg, , Germany
USIO Departamento de Oftalmologia Hospital Clínico San Carlos
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MEIBUM survey
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.